HSBC HOLDINGS PLC - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q2 2024$99,591
+5.6%
28,5770.0%0.00%
Q1 2024$94,304
-29.9%
28,577
-50.9%
0.00%
Q4 2023$134,481
+79.1%
58,2170.0%0.00%
Q3 2023$75,100
-2.3%
58,2170.0%0.00%
Q2 2023$76,846
+87.8%
58,2170.0%0.00%
Q1 2023$40,921
-5.0%
58,2170.0%0.00%
Q4 2022$43,070
-17.2%
58,2170.0%0.00%
Q3 2022$52,000
-27.8%
58,2170.0%0.00%
Q2 2022$72,000
+10.8%
58,2170.0%0.00%
Q1 2022$65,000
-31.6%
58,2170.0%0.00%
Q4 2021$95,000
-30.7%
58,2170.0%0.00%
Q3 2021$137,000
-23.9%
58,2170.0%0.00%
Q2 2021$180,000
-8.2%
58,2170.0%0.00%
Q1 2021$196,000
-7.1%
58,2170.0%0.00%
Q4 2020$211,00058,2170.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Tejara Capital Ltd 2,435,806$1,721,8710.88%
Monaco Asset Management SAM 1,316,245$930,4540.28%
DAFNA Capital Management LLC 1,096,513$775,1250.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,364,438$5,205,9210.22%
Clearline Capital LP 2,052,709$1,451,0600.22%
Rubric Capital Management LP 10,366,120$7,327,8100.19%
Orbimed Advisors 7,747,891$5,476,9840.11%
Rock Springs Capital Management LP 6,244,897$4,414,5180.10%
683 Capital Management, LLC 2,000,000$1,413,8010.10%
Privium Fund Management (UK) Ltd 177,200$131,1280.10%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders